Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
暂无分享,去创建一个
M J Lichtenstein | W A Ray | D. Blazer | W. Ray | R. Fought | K. Meador | D. Blazer | M. Griffin | M. Lichtenstein | D G Blazer | M R Griffin | J A Taylor | K G Meador | R Fought | M L Adams | J. Taylor | M. L. Adams | Margaret L. Adams | Wayne A. Ray | Jo A. Taylor | Keith G. Meador | Michael J. Lichtenstein | Marie R. Griffin
[1] L. Melton,et al. Psychotropic drug use and the risk of hip fracture. , 1987, The New England journal of medicine.
[2] S. Baker,et al. Medications and Diagnoses in Relation to Falls in a Long‐Term Care Facility , 1987, Journal of the American Geriatrics Society.
[3] W. Schaffner,et al. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. , 1983, Journal of gerontology.
[4] P. Heacock,et al. Nursing interventions for patients with Alzheimer's disease. , 1988, The Nursing clinics of North America.
[5] Michael J. Lichtenstein,et al. The Nursing Home Behavior Problem Scale. , 2018, Journal of gerontology.
[6] E. Hing,et al. Use of nursing homes by the elderly: preliminary data from the 1985 National Nursing Home Survey. , 1987, Advance data.
[7] D. Riesenberg. Drugs in the institutionalized elderly: time to get it right? , 1988, JAMA.
[8] L. Schneider,et al. A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia , 1990, Journal of the American Geriatrics Society.
[9] S. Clauser,et al. Managing behavior problems in nursing homes. , 1991, JAMA.
[10] G. Honigfeld. NOSIE--30: history and current status of its use in pharmacopsychiatric research. , 1974, Modern problems of pharmacopsychiatry.
[11] L. G. Pawlson,et al. OBRA 87 ‐ A Commentary , 1991, Journal of the American Geriatrics Society.
[12] W. Schaffner,et al. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. , 1980, American journal of public health.
[13] B. Burns,et al. Psychotropic drug prescriptions for nursing home residents. , 1988, The Journal of family practice.
[14] W A Ray,et al. Use of Medicaid data for pharmacoepidemiology. , 1989, American journal of epidemiology.
[15] B. Mcfarland,et al. Tardive dyskinesia in the aged. Duration of treatment relationships. , 1985, Archives of general psychiatry.
[16] W. Schaffner,et al. Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. , 1983, JAMA.
[17] B. Svarstad,et al. Nursing Home Resources and Tranquilizer Use among the Institutionalized Elderly , 1991, Journal of the American Geriatrics Society.
[18] Stephen B. Soumerai,et al. Improving Drug-Therapy Decisions through Educational Outreach , 1983 .
[19] J. Cohen-Mansfield. Agitated Behaviors in the Elderly: II. Preliminary Results in the Cognitively Deteriorated , 1986, Journal of the American Geriatrics Society.
[20] Paul M. Helms. Efficacy of Antipsychotics in the Treatment of the Behavioral Complications of Dementia: A Review of the Literature , 1985, Journal of the American Geriatrics Society.
[21] R. Kane,et al. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. , 1991, JAMA.
[22] M. Kendall,et al. The advanced theory of statistics , 1945 .
[23] B. O’Donnell,et al. Troublesome and Disruptive Behaviors in Dementia , 1988, Journal of the American Geriatrics Society.
[24] N. Watson,et al. Behavioral problems among patients in skilled nursing facilities. , 1984, American journal of public health.
[25] J. Rader. A comprehensive staff approach to problem wandering. , 1987, The Gerontologist.
[26] J. Avorn,et al. Psychoactive medication use in intermediate-care facility residents. , 1988, JAMA.
[27] K. Solomon,et al. The Use of Mechanical and Chemical Restraints in Nursing Homes , 1977, Journal of the American Geriatrics Society.
[28] J. Avorn,et al. Improving Medication Prescribing and Utilization in the Nursing Home , 1990, Journal of the American Geriatrics Society.
[29] B. Burns,et al. Prescribing of Psychotropics in Elderly Nursing Home Patients , 1989, Journal of the American Geriatrics Society.
[30] C. Fairburn,et al. Changes in Behaviour in Dementia: A Neglected Research Area , 1988, British Journal of Psychiatry.
[31] W. Schaffner,et al. Reducing antipsychotic drug prescribing for nursing home patients: a controlled trial of the effect of an educational visit. , 1987, American journal of public health.
[32] S R Salem-Schatz,et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. , 1992, The New England journal of medicine.
[33] W. Snow,et al. On the Clinical Value of the London Psychogeriatric Rating Scale , 1991, Journal of the American Geriatrics Society.
[34] P. Sloane,et al. Physical and pharmacologic restraint of nursing home patients with dementia. Impact of specialized units. , 1991, JAMA.
[35] J. Morris,et al. The Progression of Personality Changes in Senile Dementia of the Alzheimer's Type , 1987, Journal of the American Geriatrics Society.
[36] R. Barnes,et al. Pharmacologic Treatment of Agitation Associated With Dementia , 1986, Journal of the American Geriatrics Society.
[37] M. Tinetti,et al. Fall risk index for elderly patients based on number of chronic disabilities. , 1986, The American journal of medicine.